Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Willfact pilot trial during ECMO in adults
2016-000789-53Phase 2Terminated
- Sponsor
- Medical University of Innsbruck
- Start
- Oct 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of von Willebrand factor human in acquired von Willebrand syndrome (AVWS) (2 arms), sponsored by Medical University of Innsbruck. Primary endpoint: Daily red blood cell concentrate requirement. Started Oct 2016; status: terminated.
02
Drugs
von Willebrand factor human
03
Conditions
acquired von Willebrand syndrome (AVWS)
Beyond the preview
Go deeper on 2016-000789-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000789-53.